BILIX

WIPO WIPO 2020

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke BILIX wurde als Wortmarke am 11.11.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 11. August 2023

Markenform Wortmarke
Aktenzeichen 1571295
Länder Australien Kanada China Europäische Gemeinschaft Großbritannien Japan Vereinigte Staaten von Amerika (USA)
Basismarke KR Nr. , 03. Juli 2024
Anmeldedatum 11. November 2020
Ablaufdatum 11. November 2030

Markeninhaber

12th Fl., 364, Gangnam-daero, Gangnam-gu
Seoul
KR

Markenvertreter

#1402, Kolon Digital Tower Aston Bldg, 212, Gasan Digital 1-Ro, Geumcheon-Gu KR

Waren und Dienstleistungen

05 Pharmaceuticals; medicines for human purposes; antibiotics; anti-inflammatory preparations; anti-cancer preparations; biological preparations for the treatment of cancer; cardiovascular pharmaceutical preparations; dermatological pharmaceutical products; diagnostic preparations for medical or veterinary purposes; enzymes for medical purposes; genetic identity tests comprised of reagents for medical purposes; human vaccine preparations; medicines for dental purposes; medicines for intestinal disorders; ophthalmic preparations; pharmaceutical agents affecting digestive organs; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting peripheral nervous system; pharmaceutical agents affecting sensory organs; pharmaceutical preparations acting on the central nervous system; pharmaceutical agents for epidermis; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of musculo-skeletal disorders; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for treating skin disorders; pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of infectious diseases; pharmaceutical products for the treatment of viral diseases; pharmaceutical products for treating respiratory diseases; pharmaceuticals for the treatment of erectile dysfunction; preparations for the treatment of asthma; tumor suppressing agents; vaccines; immunoassay reagents for medical use
42 Pharmaceutical research services; drug discovery services; medical research; pharmaceutical product evaluation; scientific investigations for medical purposes; scientific research for medical purposes in the area of cancerous diseases; development of pharmaceutical preparations and medicines; consulting on the test, inspection and research of medical products; providing information on the test, inspection and research of medical products; industrial research in the fields of medicine, health and pharmacology; engineer services in the medical technology
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
09. Dezember 2022 2022/50 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
11. August 2022 2022/33 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
10. Mai 2022 2022/19 Gaz CA Ablehnung
16. Dezember 2021 2021/50 Gaz JP Ablehnung
10. Juni 2021 2021/24 Gaz EM Ablehnung
31. Mai 2021 2021/23 Gaz CN Ablehnung
27. Mai 2021 2021/21 Gaz GB Ablehnung
26. April 2021 2021/17 Gaz US Ablehnung
23. April 2021 2021/16 Gaz AU Ablehnung
11. November 2020 2021/1 Gaz KR Eintragung

ID: 141571295